Elekta to supply Advanced Radiation Therapy Treatment Equipment to Prestigious Measurement Institution

Stockholm, Sweden, March 11, 2008

Elekta is pleased to announce it has been selected to supply their Elekta Synergy® 3D IGRT Linear accelerator to The National Physical Laboratory. The National Physical Laboratory (NPL) is the UK’s National Measurement Institute and is a world-leading centre of excellence in developing and applying the most accurate measurement standards, science and technology.

For many decades NPL has carried out dosimetry work on a bespoke linear accelerator, but felt it important to have an update to clinically representative system for development of new standards, optimized for the complex treatments applied to the most challenging cancer treatments today.
Installation of the Elekta Synergy System is expected in June 2008 into a bunker specifically designed to support the advanced research and physics standards work at NPL.

Dr Simon Duane, Radiation Physics, NPL said “ Our aim is to promote best measurement practice through advice, training and services delivered using world-class, clinically relevant facilities and in this respect the Elekta Synergy system fits our requirements”

“We are aware that other standards bodies, including the NRC in Canada, had previously purchased from Elekta and this pedigree was an important factor in our decision”, he concluded.

Elekta Synergy

Elekta Synergy is an advanced digital linear accelerator integrating a suite of advanced imaging tools with a digital linear accelerator to allow 3D imaging at the time of treatment, providing clinicians with an unprecedented ability to accurately define and treat tumors.

This innovative radiation therapy treatment system directly addresses the two most persistent and significant problems in modern radiation therapy: internal organ motion and errors in patient set-up. The result is unmatched clinical confidence and enabling more aggressive treatment of tumors while minimizing damage to surrounding healthy tissue. Today, in routine clinical use at hundreds of centers around the world, Elekta Synergy provides clinicians with an unprecedented ability to accurately define and treat tumors.

David Miles, Managing Director, Elekta UK business unit commented, “The work of the NPL is recognised internationally and we are privileged to have been selected. A full range of clinical X-ray energies on a single system, including rapid triple energy switching for calibration work, was a critical requirement that had to be met. Elekta’s digitally controlled Synergy Linear Accelerator is uniquely placed to offer this versatility ”.

About The National Physical Laboratory (NPL)

NPL was established in 1900 and is a world-leading centre of excellence in developing and applying the most accurate measurement standards, science and technology available to humanity.

The majority of countries in the world have a national measurement or metrology institute. These institutes are designated by national decision to develop and maintain national measurement standards for their country. Some countries have a centralized institute that provides all measurements whilst others operate a decentralized system with many organizations taking responsibility for different measurements.

For more than a century NPL has developed and maintained the UK’s primary measurement standards. These standards underpin an infrastructure of traceability throughout the UK and the world that ensures accuracy and consistency of measurement.

Click for more information: www.npl.co.uk

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT ). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world’s largest supplier of oncology software.

Elekta’s systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 2,000 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please click here.

For further information, please contact:

Investor Enquiries:

Peter Ejemyr, Group VP Corporate Communications.
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com

Product Enquiries:

David Miles, General Manager Elekta UKBU
Tel: +44 (0) 1293 654710, email: david.miles@elekta.com

Media Enquiries:

Joanne Latimer, Healthcare Communications Specialist
Tel: +44 (0) 1293 654729, email: joanne.latimer@elekta.com